Claims for Patent: 6,745,903

Summary for Patent: 6,745,903

Title:	Methods for the on-line, on-demand preparation of sterile, water-for-injection grade water
Abstract:	A new method is described to produce large volumes of low cost sterile, Water-for-Injection (WFI) grade water on-line, on-demand from potable water in order to meet the needs of dialysis therapies and other biological applications for sterile, injectable grade water. The source water is processed by a combination of membrane and column chromatographic methods including reverse osmosis, chemical sterilization, reduction of iodine sterilant to iodide, deionization, endotoxin-specific adsorption and polishing filtration in order to reduce contaminant levels below those specified by the US Pharmacopoeia.
Inventor(s):	Grandics; Peter (Carlsbad, CA)
Assignee:
Application Number:	10/099,129
Patent Claims:	1. A method for on-line, on-demand production of sterile, water-for-injection grade water comprising the steps of: (a) filtering the water by membrane filtration; (b) sterilizing the water by chemical sterilization using solid phase iodine; (c) reducing iodine released from the solid phase iodine to iodide; (d) deionizing the water to remove iodide, residual dissolved salts, and endotoxin and (e) removing pyrogens by perfusion through an adsorbent that removes pyrogens. 2. The method of claim 1 further comprising the step of filtering the water after removal of pyrogens in step (e) by a final filtration step. 3. The method of claim 1 wherein the membrane filtration of step (a) uses reverse osmosis. 4. The method of claim 1 wherein the membrane filtration of step (a) uses ultrafiltration or nanofiltration. 5. The method of claim 1 wherein the chemical sterilization using solid phase iodine is performed on an immobilized iodine column. 6. The method of claim 5 wherein the immobilized iodine column is prepared by adsorbing Kl.sub.3 to an agarose-based strong anion exchanger containing quaternary amine groups. 7. The method of claim 1 wherein the adsorbent that removes pyrogens is a polymeric support derivatized with a multiplicity of ligands that comprise a (C.sub.10 -C.sub.24) alkylamino group and that specifically bind endotoxin. 8. The method of claim 7 wherein the alkylamino group is a stearylamino group. 9. The method of claim 7 wherein the polymeric support is agarose. 10. The method of claim 9 wherein the agarose is cross-linked. 11. The method of claim 7 wherein the support is in the form of particles. 12. The method of claim 11 wherein the particles are from about 20 to about 900 microns in diameter. 13. The method of claim 12 wherein the particles are from about 60 to about 100 microns in diameter. 14. The method of claim 7 wherein the adsorbent removes pyrogens below the level of 0.25 EU/ml. 15. The method of claim 14 wherein the adsorbent removes pyrogens below the level of 0.005 EU/ml. 16. A method for on-line, on-demand production of sterile, water-for-injection grade water comprising the steps of: (a) filtering the water by membrane filtration; (b) sterilizing the water by chemical sterilization using solid phase iodine on an immobilized iodine column prepared by adsorbing Kl3 to an agarose-based strong anion exchanger containing quaternary amine groups; (c) reducing iodine released from the solid phase iodine to iodide by using a solid phase adsorbent that has thiol groups on an agarose-based adsorbent; (d) deionizing the water to remove iodide, residual dissolved salts, and endotoxin; (e) removing pyrogens through an adsorbent that removes pyrogens and that is a polymeric cross-linked agarose support derivatized with a multiplicity of ligands that comprise a stearylamino group and that specifically bind endotoxin to remove pyrogens below the level of 0.005 EU/ml; and (f) filtering the water after the removal of pyrogens in step (e) with a final filtration step.

Details for Patent 6,745,903

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2039-09-23